BOL Pharma is a pioneering force in the creation of the medical cannabis industry in Israel since 2007. The company specializes in delivering cannabinoid related products and APIs to the pharmaceutical industry across the globe, drawing from its extensive expertise in crop production and research. With 99% pure pharma grade CBD, THC, and other active ingredients sourced from its organic GAP certified growing facilities, BOL Pharma collaborates with the Israeli Ministry of Health under governmental license to cater to thousands of patients, physicians, HMOs, and medical centers, providing cannabis-based medical products and cannabinoid APIs. As a full-service contract manufacturer, BOL Pharma also produces formulations for clinical research and offers white-label services for the pharmaceuticals, food, supplements, and cosmetics industries. Operating in the Health Care and Pharmaceutical sectors, BOL Pharma is headquartered in Israel. While specific details about its last investment and investors are not available at this time, BOL Pharma's commitment to advancing the global cannabis economy and ensuring high-quality, regulated cannabinoid products positions it as an intriguing player in the pharmaceutical and cannabis sectors.
There is no investment information
No recent news or press coverage available for BOL Pharma.